Ceribell (CBLL) Liabilities and Shareholders Equity (2023 - 2026)
Ceribell (CBLL) posted Liabilities and Shareholders Equity of $178.1 million for Q1 2026, down 9.05% on a QoQ basis from $195.8 million in Q4 2025, and down 16.58% year-over-year from $213.5 million in Q1 2025.
Ceribell (CBLL) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
Ceribell's Liabilities and Shareholders Equity history runs 4 years deep, the most recent figure standing at $178.1 million for Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 16.58% year-over-year to $178.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $781.1 million (up 60.74% YoY) and the FY2025 annual result came in at $195.8 million, down 13.14% from the prior year.
- Liabilities and Shareholders Equity was $178.1 million for Q1 2026 at Ceribell, down from $195.8 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $225.4 million in Q4 2024 and bottomed at $47.1 million in Q3 2024.
- A 4-year average of $165.7 million and a median of $197.7 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity soared 323.99% — and 2026, when it declined 16.58%.
- Ceribell's Liabilities and Shareholders Equity stood at $58.9 million in 2023, then surged by 282.56% to $225.4 million in 2024, then dropped by 13.14% to $195.8 million in 2025, then fell by 9.05% to $178.1 million in 2026.
- Business Quant data shows CBLL's Liabilities and Shareholders Equity at $178.1 million in Q1 2026, $195.8 million in Q4 2025, and $199.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | 178.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 178.08 Mn |
| Dec 31, 2025 | 195.80 Mn |
| Sep 30, 2025 | 199.53 Mn |
| Jun 30, 2025 | 207.69 Mn |
| Mar 31, 2025 | 213.47 Mn |
| Dec 31, 2024 | 225.41 Mn |
| Sep 30, 2024 | 47.06 Mn |
| Dec 31, 2023 | 58.92 Mn |